Introduction of injectable artesunate in Cameroon: lessons learned - Tene Ngoumkam, Larissa
23,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
12 °P sammeln
  • Broschiertes Buch

Cameroon, a sub-Saharan African country, is in a zone of high endemicity for malaria. This disease is the first cause of morbidity and mortality in the most vulnerable groups (children under 5 years and pregnant women). Several measures have been implemented by the Ministry of Public Health (MSP) to promote access to care, including free treatment with injectable artesunate for children under 5. The analysis will focus on the distribution system and on the trend in the use of injectable artesunate in Cameroonian health facilities one year after its introduction. This analysis is done in a…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cameroon, a sub-Saharan African country, is in a zone of high endemicity for malaria. This disease is the first cause of morbidity and mortality in the most vulnerable groups (children under 5 years and pregnant women). Several measures have been implemented by the Ministry of Public Health (MSP) to promote access to care, including free treatment with injectable artesunate for children under 5. The analysis will focus on the distribution system and on the trend in the use of injectable artesunate in Cameroonian health facilities one year after its introduction. This analysis is done in a context where the treatment of severe malaria has been routinely done for several years with quinine and injectable artemether.
Autorenporträt
Born in 1986 in Cameroon, Larissa Tene received her medical degree in 2012 and her master's in public health in 2017. Very early on, she became interested in the fight against malaria, a major cause of mortality in children under 5 years old. Hence the work done on the introduction of injectable artesunate as a treatment in her country.